A detailed history of Hartmann Taylor Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hartmann Taylor Wealth Management, LLC holds 452 shares of LLY stock, worth $388,597. This represents 0.33% of its overall portfolio holdings.

Number of Shares
452
Holding current value
$388,597
% of portfolio
0.33%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 24, 2025

BUY
$725.72 - $929.72 $328,025 - $420,233
452 New
452 $373 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $817B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hartmann Taylor Wealth Management, LLC Portfolio

Follow Hartmann Taylor Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartmann Taylor Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hartmann Taylor Wealth Management, LLC with notifications on news.